1
97
8
TSB values is similar to that reported by Maisels et al.
Conclusion
The maximum difference of 2.8mg/dl between TcB
readings and TSB values is comparable to the inter-
laboratory variat2io8 ns in TSB determination as reported
by Vreman et al and less than the difference reported
between a Bilirubinometer and Malloy-Evelyn method
of TSB determination by Owa. Therefore, the differ-
ences observed between TcB readings and TSB values
in the present study in the range of TSB of 5-18.7mg/dl
studied may be comparable to differences observed in
real clinical situations where different methods of TSB
determination are used.
The correlation between TcB and TSB levels in the
Nigerian preterm neonates is strong irrespective of the
gestational age, birth weight and TSB level.
It is recommended that transcutaneous bilirubinometry
be used routinely as a tool for the monitoring of severity
of NNJ in Blacks. This will reduce the delay in interven-
tion, minimize the problems of venepuncture and possi-
bly reduce the burden of ABE.
29
Authors Contribution
BO: Study conceptualization, data collection and
analysis, manuscript writing.
JA: Directed the study and manuscript writing.
GO: Manuscript writing and data analysis.
SO: Data analysis
Limitations
The limitations of this study include the small number of
ELBW neonates recruited and the very limited number
of bilirubin levels in the range of 15mg/dl and above.
Conflict of interest: None
Funding: None
References
1
2
.
.
Owa J, Esimai V, Olowu, Jegede.
Correlation between Readings on
Icterometer, Jaundice Meter and
Serum Bilirubin Concentrations in
Newborn Infants. Niger J Paediatr
9. De Luca D, Romagnoli C, Tiberi
16. El-Beshbishi S, Karen E, Amin A,
Petersen J. Hyperbilirubinemia and
transcutaneous bilirubinometry.
Clin Chem 2009; 55: 1280-1287.
17. Slusher T, Bode-Thomas F, Afor
F. Transcutaneous bilirubin meas-
urement and serum total bilirubin
levels in indigenous African in-
fants. Pediatrics 2004; 113: 1636-
1641.
18. Tan K, Dong F. Transcutaneous
bilirubinometry during and after
phototherapy. Acta Paediatr 2003;
92: 327-331.
19. Zecca E, Barone G, De Luca D,
Marra R, Tiberi E, Romagnoli C.
Skin bilirubin measurement during
phototherapy in preterm and term
newborn infants. Early Hum Dev
2009;85: 537-540.
20. Stillova L, Matasova K, Zibolen
M. Transcutaneous bilirubinometry
in preterm neonates. Ind J Pediatr
2009; 46: 405-408.
21. Ahmed M, Mostafa S, Fisher G,
Reynolds T.Comparison between
transcutaneous bilirubinometry and
total serum bilirubin measurements
in preterm infants <35 weeks ges-
tation. Ann Clin Biochem
E, Zuppa A, Zecca E. Skin
bilirubin nomogram for the first
96 hours of life in a European
normal healthy newborn popula-
tion, obtained with multiwave
length transcutaneous bilirubi-
nometry. Acta Paediatr 2008; 97:
146-150.
10. El-Beshbishi S, Karen E, Amin A,
Petersen J. Hyperbilirubinemia and
transcutaneous bilirubinometry.
ClinChem 2009; 55: 1280-1287.
11. Engle W, Jackson G, Stehel E,
Sendelbach D, Manning M.
Evaluation of a transcutaneous
jaundice meter following hospital
discharge in term and near-term
neonates. J Perinatol 2005; 25:486
-490.
12. Kaplan M, Shchors I, Algur N,
Bromiker R, Schimmel MS, Ham-
merman C. Visual screening
versus transcutaneous bilirubi-
nometry for predischarge jaundice
assessment. Acta Paediatr 2008;
97: 759-763.
13. Satish M, Deepak C, Ramesh A.
Transcutaneous bilirubin levels in
healthy term and late preterm In-
dian neonates. Indian J Pediatr
2010; 77:45-50.
14. Stevenson D, Wong R,Vreman H.
Reduction in hospital readmission
rates for hyperbilirubinemia is
associated with use of transcutane-
ous bilirubin measurements. Clin
Chem 2005; 51: 481-482.
15. Dai J, Krahn J, Parry D. Clinical
impact of transcutaneous bilirubi-
nometry as an adjunctive screen
for hyperbilirubinemia. Clin Bio-
chem 1996; 29: 581-586.
1
995; 22 (2): 24-30
McGil Ugwu G.I Pattern of mor-
bidity and mortality in the new-
bornspecial care unit in a tertiary
institution in the Niger Delta re-
gion of Nigeria: A two year pro-
spective study. Glo. Adv. Res. J.
Med. Med. Sci. 2012; Vol.1(6) 133
-
138,
3
4
.
.
Udo JJ, Anah MU, Etuk S, Eka-
nem AD. Neonatal morbidity and
mortality in calabar Nigeria.
Niger. J. Clin. Practice2009; 11
(3):285-289
Johnson L, Brown A, Bhutani V.
System-based approach to man-
agement of neonatal jaundice
and prevention of bilirubin en-
cephalopathy. J Pediatr 2002;
1
40: 377-386.
5
6
.
.
Shapiro SM. Bilirubin toxicity in
the developing nervous system.
Pediatr Neurol. 2003 Nov;29
(5):410-21.
Ogunlesi TA, Ogunfowora OB,
Ogundeyi MM, Ayeni VA. Jaun-
dice among hospitalized newborn
infants in Sagamu: Observations
on aetiology and clinical course.
Niger J Paediatr 2009;3&4:72-79.
Watchko J. Neonatal hyper-
bilirubinemia: what are the risks?
N Engl J Med 2006;354: 1947-49
Maisels M, Ostrea M, Touch S,
Clune S, Cepeda E, Kring E et al.
Evaluation of a new transcutane-
ous bilirubinometer. Pediatrics
2010 ;47: 72-77.
22. Knupfer M, Pulzer F, Braun L,
Heilmann A, Robel-Tillig
E,Vogtmann C. Transcutaneous
bilirubinometry in preterm infants.
Acta Paediatr 2001; 90: 899-903.
23. Siu L,Siu L, Kwong N. Minolta
JM-103 Jaundice Meter: A screen-
ing tool for neonatal jaundice in
Chinese neonates in maternal and
child health centres. HK J Paediatr
2010; 15:204-213.
7
.
8
.
2
004; 113: 1628-1635.